Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
ExpreS2ion Biotech Holding AB
EXPRS2Current price
1.17 SEK
-0.28 SEK (-19.59%)
Last closed
1.37 SEK
Company
www.expres2ionbio.com
ISIN
SE0008348262
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
70 774 997 SEK
Yield for 12 month
-26.76 %
1Y
3Y
5Y
10Y
15Y
EXPRS2
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2ion Biotechnologies ApS, researches and develops preventive and therapeutic vaccine products in the Nordics and internationally. The company's lead asset is ES2B-C001, a therapeutic vaccine for breast cancer that targets the human epidermal growth factor receptor 2 receptor. It is also developing ES2B-I002, a cytomegalovirus vaccine candidate to treat infectious diseases. In addition, the company out licenses its ExpreS2 platform to research institutes and pharmaceutical companies. Further, it sells ExpreS2 test kits and reagents for research purposes or diagnostic applications. The company has collaboration agreement with University of Oxford for the development of vaccine for malaria; and Evaxion Biotech A/S for development of cytomegalovirus vaccine, as well as partnership agreement with Copenhagen University to develop vaccine for Influenza. The company operates an online store. ExpreS2ion Biotech Holding AB (publ) was incorporated in 2015 is based in Helsingborg, Sweden. Address: Rönnowsgatan 8C, Helsingborg, Sweden, 252 25
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
26.09 SEKP/E ratio
–Dividend Yield
–Current Year
+7 019 491 SEK
Last Year
+5 063 991 SEK
Current Quarter
+1 027 536 SEK
Last Quarter
+919 006 SEK
Current Year
+3 388 274 SEK
Last Year
+4 983 SEK
Current Quarter
-12 295 558 SEK
Last Quarter
-96 576 SEK
Key Figures EXPRS2
1 year
3 years
5 years
10 years
EBITDA
-75 621 318 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-46.23 %
PEG Ratio
–
Return On Equity TTM
-58.22 %
Wall Street Target Price
26.09 SEK
Revenue TTM
8 062 955 SEK
Book Value
1.07 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
16 %
Dividend Yield
–
Gross Profit TTM
1 064 374 SEK
Earnings per share
-0.37 SEK
Diluted Eps TTM
-0.37 SEK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics EXPRS2
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EXPRS2
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation EXPRS2
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
25.3807
Enterprise Value Revenue
0.8992
Price Sales TTM
8.9224
Enterprise Value EBITDA
-1.2254
Price Book MRQ
1.3097
Financials EXPRS2
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EXPRS2
For 52 weeks
0.71 SEK
5.77 SEK
50 Day MA
0.95 SEK
Shares Short Prior Month
–
200 Day MA
2.03 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart